Eikon Therapeutics (EIKN) Stock Price, Quote, News & History | Benzinga

Eikon Therapeutics Inc (EIKN) Stock Price, Quote, News & History

EIKNNASDAQ

Trade with Public

Trade with Public

$10.31

0.080.78%

Last update: Aug 12, 2:43 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$10.21

Close

-

Volume / Avg.

201.38K / 382.04K

Day Range

$10.19 - $10.48

52 Wk Range

7.90 - 17.40

Market Cap

$558.17M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

11.96%

Days to Cover

19.96

Recent Eikon Therapeutics Inc News

Crude Oil Falls Sharply; US Durable Goods Orders Increase 0.3% In June

US stocks mixed in midday trading, Nasdaq falls 0.48%, Dow up 0.19%, S&P 500 down 0.23%. Consumer staples up 2%, tech down 1.9%. Durable goods orders rise 0.3%.

Avi Kapoor

Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks Moving Higher On Monday

Dow Jones up 400 points on Monday. Baker Hughes Co (BKR) shares rise after positive earnings and technology order. Other big gainers include NIPG, FBRX, TRAX, GENI, BMNR, OMER, ASAN, EIKN, IONQ, and SPT.

Avi Kapoor

Zebra Technologies, Vishay Precision Group, Quantum Computing, Aramark And Other Big Stocks Moving Higher On Tuesday

ZBRA, VSTS, AMBQ, VPG, BAK, PACS, LOT, EIKN, DDD, WEN, SIBN post significant gains on better-than-expected financial results and guidance. Peltz may take Wendy's private.

Avi Kapoor

Domino's Posts Downbeat Q1 Results, Joins Real Brokerage And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures mixed with Dow futures down 0.1%. Domino's Pizza misses earnings expectations, shares fall 3.8%. Other stocks also decline.

Avi Kapoor

This NextTrip Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Wall Street analysts changed outlook on top names. For all changes, upgrades, downgrades and initiations, see analyst ratings page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-223.80M

Investing Cash Flow (TTM)

-170.71M

Financing Cash Flow (TTM)

351.13M

Free Cash Flow (TTM)

-248.44M

Capital Expenditure (TTM)

-24.65M

Net Change in Cash (TTM)

-43.38M

Analyst Trends and Forecast

1

Feb

5

1

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$294.86M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.00

Earnings Yield % (TTM)

-61.94%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$10.17

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$161.15M

Debt to Equity

0.46

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$10.21

Close

-

Volume / Avg.

201.38K / 382.04K

Day Range

$10.19 - $10.48

52 Wk Range

7.90 - 17.40

Market Cap

$558.17M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

11.96%

Days to Cover

19.96

About

Sector

Health Care

Industry

Biotechnology

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating seg...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Eikon Therapeutics (EIKN) stock?

A

You can purchase shares of Eikon Therapeutics (NASDAQ:EIKN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Eikon Therapeutics (EIKN) competitors?

A

Other companies in Eikon Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Eikon Therapeutics (EIKN) stock?

A

Eikon Therapeutics has a consensus price target of $25.20.

Q

What is the current price for Eikon Therapeutics (EIKN)?

A

The stock price for Eikon Therapeutics (NASDAQ: EIKN) is $10.31 last updated August 12, 2026 at 2:43 PM EDT.

Q

Does Eikon Therapeutics (EIKN) pay a dividend?

A

There are no upcoming dividends for Eikon Therapeutics.

Q

When is Eikon Therapeutics (NASDAQ:EIKN) reporting earnings?

A

Eikon Therapeutics does not have any upcoming earnings scheduled.

Q

Is Eikon Therapeutics (EIKN) going to split?

A

There is no upcoming split for Eikon Therapeutics.

Q

What sector and industry does Eikon Therapeutics (EIKN) operate in?

A

Eikon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.